NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses
Author:
Affiliation:
1. From the Myeloma Institute for Research and Therapy, Section of Gene and Immunotherapy, University of Arkansas for Medical Sciences, Little Rock, AR; and Department of Surgery, University of Basel, Basel, Switzerland.
Abstract
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Link
http://ashpublications.org/blood/article-pdf/105/10/3939/1709144/zh801005003939.pdf
Reference66 articles.
1. Scanlan MJ, Gordan JD, Williamson B, et al. Antigens recognized by autologous antibody in patients with renal-cell carcinoma. Int J Cancer.1999;83: 456-464.
2. Old LJ, Chen YT. New paths in human cancer serology. J Exp Med.1998;187: 1163-1167.
3. Chen YT, Gure AO, Tsang S, et al. Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library. Proc Natl Acad Sci U S A.1998;95: 6919-6923.
4. Obata Y, Takahashi T, Sakamoto J, et al. SEREX analysis of gastric cancer antigens. Cancer Chemother Pharmacol.2000;46(suppl): S37-42.
5. Chen YT, Scanlan MJ, Sahin U, et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci U S A.1997;94: 1914-1918.
Cited by 165 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Advances and challenges in anti-cancer vaccines for multiple myeloma;Frontiers in Immunology;2024-08-01
2. Therapeutic strategies to enhance immune response induced by multiple myeloma cells;Frontiers in Immunology;2023-05-18
3. Adoptive Immunotherapy and High-Risk Myeloma;Cancers;2023-05-06
4. Cancer testis antigen subfamilies: Attractive targets for therapeutic vaccine (Review);International Journal of Oncology;2023-05-05
5. Safety and efficacy of letetresgene autoleucel alone or with pembrolizumab for relapsed/refractory multiple myeloma;Blood Advances;2023-03-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3